|
1.
|
Oh JW, Olman M and Benveniste EN:
CXCL12-mediated induction of plasminogen activator inhibitor-1
expression in human CXCR4-positive astroglioma cells. Biol Pharm
Bull. 32:573–577. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Sallusto F, Mackay CR and Lanzavecchia A:
The role of chemokine receptors in primary, effector, and memory
immune responses. Annu Rev Immunol. 18:593–620. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Birk D, Fortnagel G, Formentini A and
Beger HG: Small carcinoma of the pancreas. Factors of prognostic
relevance. J Hepatobiliary Pancreat Surg. 5:450–454. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Salmaggi A, Maderna E, Calatozzolo C, et
al: CXCL12, CXCR4 and CXCR7 expression in brain metastases. Cancer
Biol Ther. 8:1608–1614. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Hassan S, Ferrario C, Saragovi U, et al:
The influence of tumor-host interactions in the stromal
cell-derived factor-1/CXCR4 ligand/receptor axis in determining
metastatic risk in breast cancer. Am J Pathol. 175:66–73. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Welch DR and Goldberg SF: Molecular
mechanisms controlling human melanoma progression and metastasis.
Pathobiology. 65:311–330. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Lu C and Kerbel RS: Interleukin-6
undergoes transition from paracrine growth inhibitor to autocrine
stimulator during human melanoma progression. J Cell Biol.
120:1281–1288. 1993.PubMed/NCBI
|
|
8.
|
Wu X, Lee VC, Chevalier E and Hwang ST:
Chemokine receptors as targets for cancer therapy. Curr Pharm Des.
15:742–757. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Kato M, Kitayama J, Kazama S and Nagawa H:
Expression pattern of CXC chemokine receptor-4 is correlated with
lymph node metastasis in human invasive ductal carcinoma. Breast
Cancer Res. 5:R144–150. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Liang Z, Brooks J, Willard M, Liang K,
Yoon Y, Kang S and Shim H: CXCR4/CXCL12 axis promotes VEGF-mediated
tumor angiogenesis through Akt signaling pathway. Biochem Biophys
Res Commun. 359:716–722. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Morales J, Homey B, Vicari AP, et al:
CTACK, a skin-associated chemokine that preferentially attracts
skin-homing memory T cells. Proc Natl Acad Sci USA. 96:14470–14475.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Zlotnik A and Yoshie O: Chemokines: a new
classification system and their role in immunity. Immunity.
12:121–127. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Campbell JJ and Butcher EC: Chemokines in
tissue-specific and microenvironment-specific lymphocyte homing.
Curr Opin Immunol. 12:336–341. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Butcher EC, Williams M, Youngman K, Rott L
and Briskin M: Lymphocyte trafficking and regional immunity. Adv
Immunol. 72:209–253. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Klein RS, Rubin JB, Gibson HD, et al:
SDF-1 alpha induces chemotaxis and enhances Sonic hedgehog-induced
proliferation of cerebellar granule cells. Development.
128:1971–1981. 2001.PubMed/NCBI
|
|
16.
|
Peled A, Petit I, Kollet O, et al:
Dependence of human stem cell engraftment and repopulation of
NOD/SCID mice on CXCR4. Science. 283:845–848. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Eash KJ, Means JM, White DW and Link DC:
CXCR4 is a key regulator of neutrophil release from the bone marrow
under basal and stress granulopoiesis conditions. Blood.
113:4711–4719. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Salogni L, Musso T, Bosisio D, et al:
Activin A induces dendritic cell migration through the polarized
release of CXC chemokine ligands 12 and 14. Blood. 113:5848–5856.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Monterrubio M, Mellado M, Carrera AC and
Rodriguez-Frade JM: PI3Kgamma activation by CXCL12 regulates tumor
cell adhesion and invasion. Biochem Biophys Res Commun.
388:199–204. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Sozzani S, Allavena P, D’Amico G, et al:
Differential regulation of chemokine receptors during dendritic
cell maturation: a model for their trafficking properties. J
Immunol. 161:1083–1086. 1998.PubMed/NCBI
|
|
21.
|
Bottazzi B, Walter S, Govoni D, Colotta F
and Mantovani A: Monocyte chemotactic cytokine gene transfer
modulates macrophage infiltration, growth, and susceptibility to
IL-2 therapy of a murine melanoma. J Immunol. 148:1280–1285.
1992.
|
|
22.
|
Seo KS, Park JY, Davis WC, et al:
Superantigen-mediated differentiation of bovine monocytes into
dendritic cells. J Leukoc Biol. 85:606–616. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Leng Q, Nie Y, Zou Y and Chen J: Elevated
CXCL12 expression in the bone marrow of NOD mice is associated with
altered T cell and stem cell trafficking and diabetes development.
BMC Immunol. 9:512008. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Sasaki K, Natsugoe S, Ishigami S, et al:
Expression of CXCL12 and its receptor CXCR4 in esophageal squamous
cell carcinoma. Oncol Rep. 21:65–71. 2009.PubMed/NCBI
|
|
25.
|
Xu Q, Yuan X, Xu M, et al: Chemokine CXC
receptor 4-mediated glioma tumor tracking by bone marrow – derived
neural progenitor/stem cells. Mol Cancer Ther. 8:2746–2753.
2009.PubMed/NCBI
|
|
26.
|
Uchida D, Onoue T, Begum NM, et al:
Vesnarinone downregulates CXCR4 expression via upregulation of
Kruppel-like factor 2 in oral cancer cells. Mol Cancer. 8:622009.
View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Mirisola V, Zuccarino A, Bachmeier BE, et
al: CXCL12/SDF1 expression by breast cancers is an independent
prognostic marker of disease-free and overall survival. Eur J
Cancer. 45:2579–2587. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Sauter ER and Herlyn M: Molecular biology
of human melanoma development and progression. Mol Carcinog.
23:132–143. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Vandercappellen J, Van Damme J and Struyf
S: The role of CXC chemokines and their receptors in cancer. Cancer
Lett. 267:226–244. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Wendt MK, Johanesen PA, Kang-Decker N,
Binion DG, Shah V and Dwinell MB: Silencing of epithelial CXCL12
expression by DNA hypermethylation promotes colonic carcinoma
metastasis. Oncogene. 25:4986–4997. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Kucia M, Jankowski K, Reca R, et al:
CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion. J Mol
Histol. 35:233–245. 2004. View Article : Google Scholar : PubMed/NCBI
|
